Institute for Clinical Research Official Portal

Clinical Research Centre

Hospital Sultanah Bahiyah
Alor Setar, Kedah

WhoWe Are

 

Established in 2006, Clinical Research Centre Hospital Sultanah Bahiyah (CRC HSB) is part of a thriving network of CRCs and function as a vital bridge between the Ministry of Health, research institutions and industry partners. By fostering collaboration on crucial research projects, we empower researchers to develop solutions that directly address the needs of the underserved communities. Our unwavering commitment has demonstrably reshaped the healthcare landscape, bringing us closer to a future where quality healthcare is within reach for all.

OurTeam

NAME
 
POSITION
 
QUALIFICATION
 
EMAIL
 
Dr. Mohd Azri Bin Mohd Suan Head, Medical Officer MBBS, MSc (Epidemiology and Biostatistics) azrisuan@crc.moh.gov.my
Dr. Siti Maisarah Binti Md Ali Medical Officer MD maisarah.ma@moh.gov.my
Faizah Binti Ahmad Research Officer (Admin Manager I) BBiotech, MSc (Medical Research) faizah@crc.moh.gov.my
Noor Syahireen Binti Mohammed Pharmacist (Admin Manager II) BPharm, MSc (Social and Administrative Pharmacy) syahireen@moh.gov.my
Shahrul Aiman Bin Soelar Research Officer BSc (Industrial Statistics), MSc (Data Analysis) shahrul.aiman@crc.moh.gov.my
Siti Aishah Binti Aris Nurse Diploma in Nursing aishaharis@moh.gov.my
Mohd Faiz Bin Mustafa Nurse Diploma in Nursing faizm@moh.gov.my

 

InvestigatorsHighlight

Image

 

Head of CRC, Hospital Sultanah Bahiyah, Alor Setar

Email: azrisuan@crc.moh.gov.my

LinkedIn: www.linkedin.com/in/mohd-azri-mohd-suan-312196249 

MBBS (Malaya), MSc. Epidemiology & Biostatistics (UPM)

Areas of interest: Clinical trial, Gastroenterology & Hepatology, Public Health, Health System Research, Research Methods & Statistics

Awards and achievements:

  • Attending summer course in health research and statistics at Erasmus Medical Center, Rotterdam, The Netherland under Latihan Dalam  Perkhidmatan, 2016.
  • Recipient of Reckitt Pediatric Global Resident Scholarship Award 2024 for study on 'Types of Early Enteral Feeding for Premature Infants and Its Impact’. Qun Yuan Goh, Eric Boon Kuang Ang, Mohd Azri Mohd Suan, Shahrul Aiman Soelar. April 2024.

I am a Medical Officer and Researcher with more than 10 years of experience in the health research. My passion lies in bridging the gap between research and clinical practice to improve patient outcomes. At the Clinical Research Center, Hospital Sultanah Bahiyah, I lead a team dedicated to conducting high-quality clinical trials and promoting evidence-based healthcare practices. I possess strong research skills in areas like clinical trials, research methodology, health systems research, and medical statistics. Additionally, I have been involved in numerous Industry-sponsored research (ISR) and Investigator-initiated Trials (IIT). My research efforts have resulted in the publication of many articles in various journals. 

Research Highlights

  • Efficacy and Safety of 8- versus 12-week Treatment with sofosbuvir-Ravidasvir for Chronic, Non-Cirrhotic, Hepatitis C: Interim Analysis of a Randomized Controlled Trial in Malaysia
    • Shortening treatment: This study investigates whether reducing treatment duration from 12 to 8 weeks with sofosbuvir-ravidasvir is equally effective in curing chronic hepatitis C without cirrhosis in Malaysian patients.
    • Potential impact: Final results will be out soon. If confirmed, these findings could significantly impact hepatitis C treatment guidelines, potentially reducing treatment costs and increasing treatment accessibility.
  • Feasibility, Usability and Cost of Conventional Versus Single-Use Biodegradable Meal Trays: A Pilot Study in Hospital Sultanah Bahiyah, Alor Setar
    • Innovative solution: This study explored the potential of single-use biodegradable meal trays made from paddy straw as a sustainable alternative to conventional meal trays in a Malaysian hospital.
    • Policy implications: The findings of this study provide compelling evidence for policymakers and hospital administrators to consider adopting biodegradable meal trays as a sustainable and cost-effective solution.
  • Implementing a new Prison-based Test-and-Treat Model for Enhancing Hepatitis C Care in Kedah, Malaysia

    • Addressing a gap: This study fills a critical knowledge gap by evaluating the feasibility of a prison-based test-and-treat model for hepatitis C (HCV).

    • Policy implications: The findings support the broader adoption of prison-based test-and-treat models as a crucial component of HCV elimination strategies.

 

 

Project Highlights

 NMRR-20-328-52925
Efficacy and Safety of 8-versus 12-week Sofosbuvir-Ravidasvir Treatment for Non-Cirrhotic Chronic Hepatitis C Patients: An Open-Label, Randomized, Multicenter Study in Malaysia
 NMRR-21-02141-WI4
The Utility of M2BPGi as a Biomarker for Liver Fibrosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or Hepatitis C Infection
 NMRR-21-80-57920
Cost Analysis on Locally Manufactured Single-Use Biodegradable Hospital / Patient-Care Utensils at Hospital Sultanah Bahiyah
 NMRR-23-00196-WJ0
Investigation of The Microplastics Pathways between The Environment and The Human Colon as A Mechanism to Explain the Potential Risk of Colon Cancer
 NMRR-22-00251-0XV
Impact of Stoma Formation on The Quality of Life Among Colorectal Cancer Patients in Malaysia: A Qualitative Study
 RSCH-22-03689-Z3V
Measures to Guide the Distribution of Internal Medicine Physician
 NMRR-16-1987-33040
Understanding of Childhood Immunisation and Reasons for Refusal among the Malaysian Parents: A Qualitative Study
 NMRR-22-02970-KA2
Understanding Parental Decision-Making in the Enrollment of Children in Clinical Trials: A Qualitative Study
 NMRR-22-02260-DHZ
Attitudes and Beliefs to Use of Medical Cannabis among Malaysian’s Doctors
 NMRR-22-00003-6NQ
Effect of High Dose Intravenous Vitamin C as an Adjunct in the Treatment of Patients with Severe Pneumonia in Intensive Care Unit: A Multi-Center, Double-Blinded, Two-Arm, Placebo-Controlled, Randomized Trial
 NMRR-15-596-25330
Cost Efficiency Analysis of Malaysian Hospitals
 NMRR-22-02345-5QG
Cholangiocarcinoma Incidence, Trends, Risk Factor and Survival Rate in Northern Region of Malaysia: Analysis of 10 Years Data (2012-2022)
 RSCH-23-00015-TOP
Economic Evaluation of Sofosbuvir-Ravidasvir Treatment for Non-Cirrhotic Chronic Hepatitis C Patients: An Extension of EASE Trial
 NMRR-20-2288-56852
10-year Prevalence of Non Syndromic Cleft Lip, Cleft Palate and Cleft Lip and Palate among Children Born in a Tertiary Hospital, Malaysia: A Retrospective Study
 NMRR-22-02371-5NY
Public Perception on Generational End Game (GEG)
 RSCH-22-01041-7RV
Barriers to Colorectal Cancer Screening in Malaysia: A Systematic Review
 NMRR-22-02802-JMO
Development of Validated Predictive Pharmacodynamic Models of Initial Warfarin Dose: A Mixed-Method Study
 NMRR-19-1188-47227
Investigation of Urinary MicroRNA as Potential Biomarker for Colorectal Cancer Detection
 NMRR-19-1013-47474
The Evaluation of 13 Years Behavioural Modification in Smoking Cessation Programme by Health Educators at Hospital Sultanah Bahiyah, Alor Setar
 NMRR-18-3157-44781
Trending of Comprehensive Dental Treatment Under General Anesthasia in 8 Years at Paediatric Dental Clinic, Hospital Sultanah Bahiyah, Alor Setar
 NMRR-23-00545-UTT
Clinical Outcome of COVID-19 Patient in Intensive Care Unit Hospital Sultan Abdul Halim in 2021
 NMRR-21-174-57969
Molar Tooth Survival of Periodontal Patients Following Periodontal Therapies in Klinik Pakar Periodontik Kota Setar
 NMRR-20-1217-55489
Facial Anthropometry Survey Among Malaysian for The Development of Bivariate and Principal Component Analysis Facial Panel
NMRR-20-2807-57057
Phase II/III Randomized, Controlled Clinical Study of AlloStim® VS. Physician's Choice in Asian Subjects with Advanced Hepatocellular Carcinoma
NMRR-20-102-52746
Identifying and Developing Chromosomal Conformation Signatures for Gastrointestinal Cancers
NMRR-23-00652-I4A
Identifying and Developing Chromosomal Conformation Signatures for Early Screening and Diagnosis of Colorectal Cancer
NMRR-20-1140-53693
Treatment of CVD with Low dose Rivaroxaban in Advanced CKD (TRACK)
NMRR-19-3823-52045
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events (RESOLVE)
NMRR-22-00178-HCX
A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (CPI-0610) and Ruxolitinib vs Placebo and Ruxolitinib in JAKi Treatment Naïve MF Patients (MANIFEST-2)
NMRR-22-02468-BUD
A Phase IIIb, Multi-Center, Open-Label, Randomized Study of Tolerability and Efficacy of Oral Asciminib versus Nilotinib in Patients with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (CABL001J12302)
NMRR-22-02956-NIS
A Phase 2B Randomized, Double-Blind, Active and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn’s Disease (DUET-CD)
NMRR-17-1636-36783
A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescennts (≥10 to <18 years) with Type 2 Diabetes Mellitus (DIA)
NMRR-19-1258-47901
Semaglutide Cardiovascular Outcomes Trial in Patient with Type 2 DM (SOUL)
NMRR-19-770-47233
A Phase 3b, Open Label, Single-Arm, Rollover Study to Evaluate Long-Term Safety in Subjects who have Participated in Other Luspatercept (ACE-536) Clinical Trials (ACE-536-LTFU-001)
NMRR-21-01964-JHU
A Phase 3, Double-Blind, Randomised, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subject with Non-Tranfusion-Dependent Alpha- or Beta-Thalasemia (ENERGIZE)
NMRR-21-01965-4JL
A Phase 3, Double-Blind, Randomised, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects with Tranfusion-Dependent Alpha- or Beta-Thalasemia (ENERGIZE-T)

Scope of Training and Services

Image
Image

Meet Our Collaborators

Client 1
Client 1
Client 1
Client 1
Client 1
Client 1
Client 1

Kindly visit CRC Kedah for further info on upcoming activities

CRC Hospital Sultanah Bahiyah, Kedah

Clinical Research Centre
Level 2, Hospital Sultanah Bahiyah
KM 6 Jalan Langgar
05460 Alor Star, Kedah

Main Phone: +604-740 6227/6228/6229/7390/7391
Email: crc.hsbkedah@gmail.com 

 

 

ICR
National Institutes of Health (NIH)
Ministry of Health Malaysia
Institute For Clinical Research
Block B4, National Institutes of Health (NIH)
No.1, Jalan Setia Murni U13/52, Seksyen U13
40170 Shah Alam, Selangor Darul Ehsan
Malaysia
 
Phone: 603-3362 7700
Email: contact@crc.gov.my
 

NIH Official Portal

Client 1

Follow us on